Purple glove syndrome
From Wikipedia, the free encyclopedia
Purple Glove Syndrome (PGS) is a poorly understood skin disease in which the extremities become swollen, discoloured and painful.[1] PGS is potentially serious, and may require amputation. PGS is most common among elderly patients and those receiving large, multiple intravenous doses of the epilepsy drug phenytoin.[2]
In November 2010, the FDA's Peripheral and Central Nervous System Drugs Advisory Committee recommended that new warnings be added to phenytoin intravenous (IV) about the risk of purple glove syndrome.[3]
[edit] References
- ^ Chokshi R, Openshaw J, Mehta NN, Mohler E (February 2007). "Purple glove syndrome following intravenous phenytoin administration". Vasc Med 12 (1): 29–31. doi:10.1177/1358863X07076551. PMID 17451091. http://vmj.sagepub.com/cgi/pmidlookup?view=long&pmid=17451091.
- ^ O'Brien TJ, Cascino GD, So EL, Hanna DR (October 1998). "Incidence and clinical consequence of the purple glove syndrome in patients receiving intravenous phenytoin". Neurology 51 (4): 1034–9. PMID 9781525.
- ^ http://www.aboutlawsuits.com/dilantin-pgs-warning-14041/
[edit] External links
- FDA: Potential Signals of Serious Risks/New Safety Information Identified by the Adverse Event Reporting System (AERS) -- January - March 2008
 |
This disease article is a stub. You can help Wikipedia by expanding it. |
